iShares Biotechnology ETF IBB

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IBB

Will IBB outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Biotechnology ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBB

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 44.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Vertex Pharmaceuticals Inc

7.83 732M
Healthcare

Amgen Inc

7.81 730M
Healthcare

Gilead Sciences Inc

7.13 667M
Healthcare

Regeneron Pharmaceuticals Inc

5.23 489M
Healthcare

argenx SE ADR

3.56 333M
Healthcare

Alnylam Pharmaceuticals Inc

2.99 280M
Healthcare

Natera Inc

2.91 272M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.74 256M
Healthcare

Biogen Inc

2.39 224M
Healthcare

Illumina Inc

2.24 210M
Healthcare

Sponsor Center